Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2005
09/15/2005US20050202091 Stable pharmaceutical composition comprising erythropoietin
09/15/2005US20050202076 Stabilization, homogenizing, sterile filtration, dehydration, reconstitution, ultrafiltration; storage stability; taxanes
09/15/2005US20050202064 Administering an uronic acid or uronic acid derivative, a saccharide; anticarcinogenic
09/15/2005US20050202035 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor
09/15/2005US20050202033 Heat shock protein-based vaccines and immunotherapies
09/15/2005US20050202027 Multivalent compounds for crosslinking receptors and uses thereof
09/15/2005US20050202022 Polynucleotides encoding humanized antibodies against human 4-1BB
09/15/2005US20050202019 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
09/15/2005US20050202018 Binding agent, conjugated to a keyhole limpet hemocyanin, that specifically binds to circulating prostate specific antigen and induces a therapeutic immune response
09/15/2005US20050202016 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050202007 Determining a P-selectin activity in a biological sample of the subject,increased P-selectin activity in the sample indicates a procoagulant state in the subject
09/15/2005US20050201986 Cell targeting compositions and methods of using the same
09/15/2005US20050201980 Method for short-term and long-term drug dosimetry
09/15/2005US20050201979 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005US20050201940 Diagnostics and radiotherapy; magnetic resonance imaging (MRI); treatment of a tumor
09/15/2005US20050201939 Dye-peptide complex; supplying to tumor cells; for diagnostic imaging and therapy; biocompatibility
09/15/2005US20050201934 Binding peptides for carcinoembryonic antigen (CEA)
09/15/2005DE4126475B4 13-Dihydro-3'-(2-Alkoxy-4-morpholinyl)anthracycline, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Zusammensetzungen 13-dihydro-3 '- (2-alkoxy-4-morpholinyl) anthracyclines, processes for their preparation, their use and compositions containing them
09/15/2005CA2558813A1 Pharmaceutical composition comprising cxcr3 inhibitor
09/15/2005CA2558667A1 Antisense oligonucleotides for inhibiting the formation of metastases in cancer
09/15/2005CA2558600A1 A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
09/15/2005CA2558399A1 Partially loaded antibodies and methods of their conjugation
09/15/2005CA2557989A1 Sulfated oligosaccharide derivatives
09/15/2005CA2557857A1 Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation
09/15/2005CA2557610A1 Use of carboxypeptidase g for combating antifolate toxicity
09/15/2005CA2557581A1 Inhibitors of dna methylation in tumor cells
09/15/2005CA2557302A1 Pyridinamide derivative as kinase inhibitors
09/15/2005CA2557270A1 Pyrrole-derivatives as factor xa inhibitors
09/15/2005CA2556386A1 Isothiourea derivatives
09/15/2005CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
09/15/2005CA2555161A1 Novel 4-benzimidazol-2-yl-pyridazin-3-one derivatives
09/14/2005EP1574856A1 Method of screening cell growth inhibitor and cell growth inhibitor
09/14/2005EP1574574A1 Exon 1-beta of pdgf receptor alpha gene and utilization thereof
09/14/2005EP1574519A1 Transcription control factor ZHX3
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1574499A1 Inhibitors of DNA methylation in tumor cells
09/14/2005EP1574213A1 Use of histone deacetylase inhibitors for increasing therapeutic gain in radiotherapy and chemotherapy
09/14/2005EP1573031A2 Androgen regulated nucleic acid molecules and encoded proteins
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1573003A2 Method for producing transgenic animals using oral gene therapy
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572989A1 Gen 2.2 dendritic cell line
09/14/2005EP1572976A2 Modulating immune responses
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572935A2 Methods of making hypermutable cells using pmsr homologs
09/14/2005EP1572933A2 Modulation of immune response by non-peptide binding stress response polypeptides
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572916A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
09/14/2005EP1572905A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572876A2 Transcriptional regulation of target genes
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572726A2 4-methylhexanoic kahalalide f compound
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572715A1 Steroid compounds with anti-tumor activity
09/14/2005EP1572695A1 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy
09/14/2005EP1572686A1 Anthranilic acid amide derivatives and their pharmaceutical use
09/14/2005EP1572675A1 New alpha-glucosidase inhibitors and their synthesis from a natural source
09/14/2005EP1572673A1 Antioxidant from natural source
09/14/2005EP1572625A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
09/14/2005EP1572299A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
09/14/2005EP1572246A2 Novel compositions of magnetic particles covered with gem-bisphosphonate derivatives
09/14/2005EP1572243A1 Induction of tolerance through oral administration of a therapeutic agent coupled to a transporting agent
09/14/2005EP1572242A1 Immunoconjugates with an intracellularly-cleavable linkage
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005EP1572210A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/14/2005EP1572194A1 Anti-cancer composition comprising dmxaa or related compound
09/14/2005EP1572191A1 Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings
09/14/2005EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572134A2 Protein s protects the nervous system from injury
09/14/2005EP1572125A2 Compositions and methods for treating tumors bearing hmfg and cea antigens
09/14/2005EP1572106A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
09/14/2005EP1572103A2 Anti-angiogenic uses of il-6 antagonists
09/14/2005EP1572101A2 Disease treatment via antimicrobial peptide inhibitors
09/14/2005EP1572100A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572087A2 Antibodies against cancer antigen tmeff2 and uses thereof
09/14/2005EP1572083A2 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572075A2 Method for treating diseases associated with abnormal kinase activity
09/14/2005EP1572074A2 Stabilized synthetic immunogen delivery system
09/14/2005EP1572067A2 Conjugates and compositions for cellular delivery
09/14/2005EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/14/2005EP1529048A4 Methods for the synthesis of substituted purines
09/14/2005EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48
1 ... 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 ... 2211